Search Results
Andrew Callos of Pfizer on sustainable business in rare disease at World Orphan Drug Congress USA
Andrew Callos of Pfizer on building a rare disease franchise at World Orphan Drug Congress USA 2013
Andrew Callos of Pfizer on sustainable business in rare disease
Rare disease and orphan drugs: industry executives at World Orphan Drug Congress USA
Brenda Cooperstone on Pfizer's rare disease portfolio at World Orphan Drug Congress USA 2013
Freda Lewis-Hall of Pfizer on next gen orphan drugs at World Orphan Drug Congress USA 2013
Orphan drugs and rare diseases: pharma executives at the World Orphan Drug Congress USA 2011
Anne Pariser of the FDA on natural history studies in rare disease at World Orphan Drug Congress USA
Rare disease clinical trials with Shire, Novartis and more at World Orphan Drug Congress USA 2013
Pfizer's Rare Disease Unit - Advancing the Discovery, Development, and Availability of Orphan Drugs
Orphan drug discoveries & academic centers of excellence at World Orphan Drug Congress USA
Angus Russell of Shire on social responsibility in rare diseases at World Orphan Drug Congress USA
